Safety and efficacy of the Russian COVID-19 vaccine: more information needed-Reference-Cited by-同舟云学术

Safety and efficacy of the Russian COVID-19 vaccine: more information needed

Published:2020-10 Issue:10256 Volume:396 Page:e53
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bucci Enrico,Andreev Konstantin,Björkman Anders,Calogero Raffaele Adolfo,Carafoli Ernesto,Carninci Piero,Castagnoli Paola,Cossarizza Andrea,Mussini Cristina,Guerin Philippe,Lipworth Brian,Sbardella Gianluca,Stocki Teresa,Tuosto Loretta,van Tulleken Christoffer,Viola Antonella

Publisher

Elsevier BV

Subject

General Medicine

Reference1 articles.

1. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia;Logunov;Lancet,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical Evaluations of Clinical Trials in France: Towards European Standardization;Philosophy and Medicine;2023

2. Post COVID-19 vaccination side effects and associated factors among vaccinated health care providers in Oromia region, Ethiopia in 2021;PLOS ONE;2022-12-08

3. Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case–control study;Respiratory Research;2022-10-10

4. Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study;BMC Medicine;2022-09-20

5. Intelligent Covid-19 Vaccine Supplychain Management System;2022 13th International Conference on Information and Communication Systems (ICICS);2022-06-21